Unlocking the Deep Human Genome - Interview with Jo Bhakdi

In this episode, we welcome Jo Bhakdi, Founder & CEO of Quantgene, a company that is unleashing the power of the Deep Human Genome by building and deploying the world’s leading Deep Genomics solution. Jo and his team have quickly created next-day 99.9% accurate COVID-19 testing solutions for individuals and institutions and he’s here today to talk about that incredible accomplishment. As the go-to testing supplier in Los Angeles, he’s even helped the film industry get up and running again after the pandemic halted production and they’ve expanded to other cities as well. He delves into why covid-19 was beneficial in fostering the creation and growth of start-ups, specifically in the technology and healthcare fields, and details the fundamentals and importance of the Serenity genetics engine. Jo also speaks on his ventures in creating i2X, a new framework for investing in tech startups, and divulges some of his key principals of innovation.Want to learn what the future of medicine and healthcare looks like with these advancements in technology? Curious to know Jo’s perspective on what innovations we may see in the next decade? Tune in to find out! About Our Guest:Jo Bhakdi is the Founder and CEO of Quantgene, an innovative technology company whose mission is to extend the healthy human lifespan by 10 years within the next 10 years. He leads a team of 22 that is growing quickly and he has raised $13 million to date, expecting to end next year with more than 10,000 members.Follow Jo on Twitter: www.twitter.com/JOBhakdiFollow Quantgene on Twitter: www.twitter.com/quantgeneTo learn more about Quantgene, visit www.quantgene.com